|

DSB2455 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Duke Street Bio Ltd1

Indications

  • Advanced Malignancies With Homologous Recombination Deficiency (HRD) (Breast, Ovarian, mCRPC, Brain Metastases)1
  • Breast Cancer1
  • Cancer1

New Haven, Connecticut1 trial

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Yale Cancer Center - Yale New Haven Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.